MedPath

Evaluating the Efficacy of Cinnamunum Tamala on decreased libido , in SSRI induced sexual dysfunction(libido) in patients with neurologic and psychotic disorders

Phase 3
Conditions
Condition 1: depression. Condition 2: adverse effect of SSRIs. Condition 3: sexual dysfunction due to taking SSRI drugs.
Major depressive disorder, single episode, mild
Y49.2Other and unspecified antidepressants
Sedative, hypnotic, or anxiolytic related disorders
F32.0
Y49.2
Registration Number
IRCT20240813062746N1
Lead Sponsor
Research group of school of traditional medicine of Iran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
46
Inclusion Criteria

Taking one of SSRI drugs at least for one month ,
decreased libido after taking SSRI drugs ,
being married ,
consent

Exclusion Criteria

metabolic disorders ,
taking drugs such as anti-hypertension, anti-coagulant , anti-diabetic and cardiac
pregnancy
breastfeeding mothers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ibido. Timepoint: at begin and after 8 weeks. Method of measurement: Arizona questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath